IMRT Used Less in Black Prostate Cancer Patients
Researchers confident in this approach because candidates for active surveillance are screened.
African Americans are less likely than Caucasians to receive intensity-modulated radiation therapy (IMRT) for localized prostate cancer (PCa), according to a study published online in the American Journal of Men's Health.
Using the Surveillance, Epidemiology and End Results (SEER)-Medicare linked database, Ewan K. Cobran, PhD, of the University of Georgia College of Pharmacy, and collaborators studied 947 black and 10,028 white men diagnosed with localized PCa from 2002 through 2006 and treated with either IMRT or non-IMRT.
The proportion of patients who received IMRT was 45% among African Americans and 53% among Caucasians, a significant difference between the groups.